October 23, 2020October 23, 2020
Phase 2 Trial of Haduvio for Chronic Cough Due to IPF Again Enrolling in UK

A Phase 2 study of Haduvio (nalbuphine extended release tablets) to treat chronic cough in people with idiopathic pulmonary fibrosis (IPF) is again enrolling eligible ... Read more
October 22, 2020October 22, 2020
Telehealth ‘Helpful’ Alternative to In-person Care, Rare Disease Patients Say

A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like the option of continuing its ... Read more
October 21, 2020October 21, 2020
Ultrasound Approach May Offer Safer, Less Costly Way of Diagnosing IPF

A new way of assessing ultrasound, a non-invasive technique using sound waves to produce pictures inside of the body, may be effective in diagnosing ... Read more
October 20, 2020October 20, 2020
Trial to Test Higher Dose of Inhaled Pirfenidone in All Participants

All patients in a Phase 1/2 trial examining two doses of AP01, an inhaled version of pirfenidone for the treatment of idiopathic pulmonary fibrosis ... Read more
October 19, 2020October 19, 2020
Phase 2 Trial of NP-120 for IPF Reaches 25% of Enrollment Target

A Phase 2 study of NP-120 (ifenprodil) for chronic cough associated with idiopathic pulmonary fibrosis (IPF) has reached 25% of its enrollment target, Algernon Pharmaceuticals, ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

April 27, 2018April 27, 2018

Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests

News

Treatment with plant-derived aloperine reduces the severity of lung injury in a mouse model of pulmonary fibrosis, a new Chinese study reports. The research, “Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation,” was published ... Read more

Phase 2 Trial of Haduvio for Chronic Cough Due to IPF Again Enrolling in UK

Telehealth ‘Helpful’ Alternative to In-person Care, Rare Disease Patients Say

Ultrasound Approach May Offer Safer, Less Costly Way of Diagnosing IPF

Trial to Test Higher Dose of Inhaled Pirfenidone in All Participants

Phase 2 Trial of NP-120 for IPF Reaches 25% of Enrollment Target

Phase 2 Trial of NP-120 for IPF Reaches 25% of Enrollment Target

Mental Healthcare Is Important When Chronically Ill or Caregiving

Spred2 Gene Plays Possible Role in PF Development, Mouse Study Finds

Avoid Toxic Positivity to Help PF Patients

Inhalable Signaling Protein BMP4 May Be Potential Treatment Approach for IPF

Large Chest Lymph Nodes in IPF Patients Tied in Study to Higher Risk of Mortality

Subscribe to our mailing list

Continuous Blood Filtration Shows Potential for Treating Paraquat-induced PF

The Importance of Peer Support for Pulmonary Fibrosis Patients

Same But Different Asks Public to Vote on ‘Glimmer of Hope’ Calendar Photos

Lung Function Decline After Antifibrotic Therapy Predicts Survival in IPF, Study Shows

ATS Offering Total of $150K for Research Into IPF, Asthma, COPD

Galecto Raises $64M to Help Advance GB0139 as Inhalation Therapy for IPF

I Was a Different Person Before and After My IPF Diagnosis

TL1A Protein and Its Receptor Drive Lung Fibrosis, Study Finds

Canadian Research Partnership Will Focus on Progressive Fibrosing ILDs

Mortality Risk Lower for IPF Patients Diagnosed More Recently, Study Suggests

Keep the Whole System Running by Maintaining the Parts

Veracyte’s Genomic Diagnostic Test for IPF Earns Special Medicare Status

Making Exercise Easier: Tips From a Pulmonary Fibrosis Patient

UK Training Module Aims to Help Physicians Improve PF Care, Awareness

Bilirubin Levels May Reveal Severity, Predict Progression of IPF, Study Finds

Across the Globe, Supporters Go Blue for PF Awareness Month

New 3D Lung Model Points Away From Tissue Stiffening as Key to Fibrosis

Cymerus MSCs Seen to Ease IPF Symptoms in Mouse Model of Disease

PFF Sharing Patient Stories, Photos to Mark PF Awareness Month

Prednisone and Self-image: Transplant Side Effects We Don’t Talk About

Procalcitonin Blood Levels May Help Detect Lung Cancer in IPF Patients, Study Suggests

Pulmonary Fibrosis Is Like a Storm Cloud Over My Future

Inhaled Nintedanib May Reduce Side Effects of Oral Formulation, Rat Study Shows

Ofev Effective in IPF Patients With Poor Lung Function, Real-world Study Finds

NIH Grants $10M to Study Immune Cells’ Role in Lung, Heart Transplant Rejection

Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests

Pin It on Pinterest